News
Limno’s presentation at the EIT Health Summit 2019
Limno's presentation at the EIT Health Summit 2019. Here is the link: https://summit.eithealth.eu/
read moreLimno’s presentation at MedInBio (Nov 26, 2019)
Limno's presentation at MedInBio. Here is the link to the programme: https://medinbio.es/programa-2019/
read moreLimno’s presentation at Innova Health (Oct 29, 2019)
Limno's presentation at Innova Health. Here is the link to the programme: http://www.innovahealth.net/Programa/
read moreLimno’s presentation at the Medical Association of Barcelona (Oct 23, 2019)
Limno's presentation at the Medical Association of Barcelona. Here is the link to the programme: https://www.comb.cat/cast/altres/forumhealthcare/25forum_inversio.html
read moreLimno’s presentation at the ASEBIO Investor Day (Sept 26, 2019)
Limno's presentation at the ASEBIO Investor Day. Here is the link: https://asebioevents.com/investorday/presenting-companies/
read moreLimnopharma: semifinalist at the Everis Awards 2019
Limnopharma: semifinalist at the Everis Awards 2019.
read moreLimnopharma presentation
Limnopharma is the first company to find a treatment to cure Retinitis Pigmentosa (RP) and Age-Related Macular Degeneration (AMD).
read moreThe cure for eye diseases that cause blindness
The biotechnology start-up will be at Alhambra Venture 2019 Around 250 million people live with visual disabilities worldwide. Age-related Macular Degeneration (AMD) and Retinitis Pigmentosa (RP) are two of the diseases that cause visual impairment and blindness. They...
read more
New therapies for retinal diseases.
Treatments for Age-Related Macular Degeneration (AMD) and Retinitis Pigmentosa (RP)
Headquarters
Edif Reina María,
Carretera Bailén-Motril, S/ N
Parc 102,
18210 Peligros, Granada